Echinacea is an herbal supplement widely used for its immunomodulatory properties, thought to be driven by compounds like alkamides and polysaccharides. Its relevance to healthspan is indirect, focusing on potentially reducing the duration and severity of acute upper respiratory infections. By mitigating the burden of common illnesses, it supports immune resilience, but it does not directly target primary aging pathways.
Verdict
Useful for acute cold symptoms, but not a core healthspan intervention.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Low
EVIDENCE GRADE
B
MONTHLY COST
$10 - $25
Protocol
- Typically used for 7-14 days at the onset of cold or flu symptoms.
- Common protocols involve 300-500 mg of standardized extract taken three times daily during acute illness.
Flags
- Not recommended for long-term, continuous use due to potential immune system effects.
- May interact with immunosuppressant drugs, potentially reducing their effectiveness.
- Individuals with autoimmune diseases (e.g., lupus, rheumatoid arthritis) should use with caution.
- Allergic reactions are possible, especially for those allergic to the Asteraceae family (ragweed, daisies).